GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results
Go back to GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results| (NASDAQ: GTBP) | Delayed: 6.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.89 | 52 Week High | $ | |||
| Open | $6.89 | 52 Week Low | $ | |||
| Day High | $6.89 | P/E | N/A | |||
| Day Low | $6.89 | EPS | $ | |||
| Volume | 123 | |||||
